Cilostazol Tablets
Function and Efficacy
The mechanism of action of this product in improving intermittent thromboembolism symptoms is not yet fully understood. This product and its metabolites are cyclic adenosine monophosphate (cAMP) phosphodiesterase III inhibitors (PDEIII inhibitors), which can reduce the degradation of cAMP by inhibiting the activity of phosphodiesterase, thereby increasing the cAMP level in platelets and blood vessels, inhibiting platelet aggregation and vasodilation.
Ingredients
The main ingredient of this product is cilostazol, and its chemical name is: 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolone
| Name | Description | Content | CAS NO. | Manufacturer |
|---|---|---|---|---|
| CilostazolIngredients |
This product and its metabolites are cyclic adenosine monophosphate (cAMP) phosphodiesterase III inhibitors (PDEIII inhibitors), which can reduce the degradation of cAMP by inhibiting the activity of phosphodiesterase, thereby increasing the cAMP level in platelets and blood vessels, inhibiting platelet aggregation and vasodilation. More |
73963-72-1 | 30 |
Appearance
This product is white or off-white tablets.
Indication
Improve symptoms such as chronic ulcers, pain, chills and intermittent claudication caused by chronic arteriosclerosis obliterans.
Usage and Dosage
Oral administration: 100 mg at a time (2 50 mg tablets or 1 100 mg tablet), 2 times a day. The dosage can be increased or decreased according to the condition.
Adverse Reactions
1 Systemic adverse reactions: abdominal pain, back pain, headache, infection, edema. 2 Circulatory system: occasional palpitations, rapid pulse, fever, dizziness, hypotension. 3 Digestive system: occasional stomach discomfort, upper abdominal pain, abdominal distension, loss of appetite, nausea, vomiting, soft stools, diarrhea. 4 Allergic reactions: occasional rash, eruptions, urticaria, itching. 5 Nervous system: occasional headache, heavy head, dizziness, vertigo, insomnia, numbness, occasional drowsiness, fatigue. 6 Liver: occasional increase in AST, ALT, LDH values. 7 Kidney: occasional increase in BUN, creatine, uric acid values
Precautions
1. Patients who are allergic to any component of this drug. 2. Patients with grade 3-4 congestive heart failure. 3. Patients with bleeding such as hemophilia, capillary fragility, upper gastrointestinal bleeding, hemoptysis, etc. 4. Women who are pregnant or may become pregnant.
Special Population Medication
Precautions for children: The safety of children's use has not been established. Precautions for pregnancy and lactation: It is forbidden for women who are pregnant or may become pregnant. Precautions for the elderly: It is not clear yet.
Drug Interactions
Prostaglandin E1 works synergistically with this product to increase intracellular cyclic guanosine-phosphate and enhance therapeutic efficacy.
Storage
Store in airtight container at room temperature. Valid for 24 months.
Packaging Specification
50mg
Validity Period
24 months
Manufacturer
Penglai Nuokang Pharmaceutical Co., Ltd.
-
Founded in:
2002-06-07 -
Address:
No. 118, Jinchuang Road, Penglai City, Shandong Province -
Tax NO.:
913706007392965167 -
Registered Funds:
92.7117 million yuan -
Email: